HIV Reverse Transcriptase-Mediated Mutagenesis
HIV Reverse Transcriptase-Mediated Mutagenesis
批准号:
8930342
负责人:
Baek Kim
金额:
$0.95万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-15 至 2017-05-31
关键词:
AffinityAnti-Retroviral AgentsAntiviral AgentsAutomobile DrivingBase PairingBindingBiochemicalCell Culture TechniquesCellsChemosensitizationDNADNA biosynthesisDecitabineDefense MechanismsDevelopmentDrug CombinationsDrug resistanceEnzymesExtinction (Psychology)FrequenciesGenomeGoalsHIVHIV-1HealthImmune systemInduced MutationKineticsLeadLife Cycle StagesMediatingMethodologyMethodsMolecularMutagenesisMutateMutationNatureNucleic AcidsNucleosidesPharmaceutical PreparationsPopulationPreparationProteinsRNA-Directed DNA PolymeraseReverse Transcriptase InhibitorsRibonucleotide Reductase InhibitorSpecificityStructure-Activity RelationshipToxic effectUncertaintyViralViral GenomeVirusanalogbasedrugged drivinggemcitabinein vivo Modelinsightnovel therapeutic interventionnucleoside analogscreeningsmall moleculetripolyphosphateviral DNA
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): HIV-1 has a high mutation rate, which contributes to its ability to evade the host immune system, limits the efficacy of antiretroviral drugs and drives
the emergence of drug resistance. Drug resistance conferring mutations as well as other viral mutations are primarily attributed to the error-prone nature of reverse transcriptase (RT). An intentional increase in RT-mediated mutations decreases virus infectivity by increasing the mutation rate to a level that is not able to maintain survival of the virus population. The potency
by which HIV-1 infectivity can be decreased by increasing RT-mediated errors has led to an initiative to discover small molecules that may increase the HIV-1 mutation rate. An interdisciplinary collaborative team has been assembled to 1) conduct discovery studies to identify new small molecules that increase RT-mediated errors, 2) use molecular analyses to identify the mechanism(s) by which small molecules increase the HIV mutation rate and result in virus extinction, and 3) to assess the mechanism of RT-mediated mutation using biochemical methods. Through preliminary studies, we have identified four small molecules that increase RT-mediated mutations. In order to elucidate the structure-activity relationship driving this increase and to optimize this activity, we will first pursue discovery studies to identify small molecules that can increase RT-mediated errors. The antiviral and mutagenic activities of these molecules will be assessed in cell culture. Second, we will examine the mechanism by which small molecules induce mutations and cause virus extinction in HIV-1 using cell culture methodologies. Here we will examine small molecules that we have already discovered as well as any lead molecules that we identify. Third, we will investigate the mechanism of action using biochemical methods to elucidate the mechanistic basis for increased RT-mediated mutation. Successful completion of these studies will provide deeper insight into the mechanisms of RT-mediated viral mutagenesis and its impact on viral replication and extinction.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SAMHD1 mediated dNTP regulation and HIV in myeloid cells
-
批准号:10616679
-
项目类别:
-
资助金额:$68.89万
-
财政年份:2021
-
负责人:Baek Kim
-
依托单位:
SAMHD1 mediated dNTP regulation and HIV in myeloid cells
-
批准号:10398255
-
项目类别:
-
资助金额:$41.53万
-
财政年份:2021
-
负责人:Baek Kim
-
依托单位:
SAMHD1 mediated dNTP regulation and HIV in myeloid cells
-
批准号:10271627
-
项目类别:
-
资助金额:$38.67万
-
财政年份:2021
-
负责人:Baek Kim
-
依托单位:
SARS-CoV-2 polymerase inhibitor screening
-
批准号:10230304
-
项目类别:
-
资助金额:$20.8万
-
财政年份:2020
-
负责人:Baek Kim
-
依托单位:
Elucidating SAMHD1 in DNA Double-Strand Break Repair (Supplement)
-
批准号:10817401
-
项目类别:
-
资助金额:$5.69万
-
财政年份:2020
-
负责人:Baek Kim
-
依托单位:
Elucidating SAMHD1 in DNA Double-Strand Break Repair
-
批准号:10214575
-
项目类别:
-
资助金额:$51.06万
-
财政年份:2020
-
负责人:Baek Kim
-
依托单位:
Elucidating SAMHD1 in DNA Double-Strand Break Repair (Supplement)
-
批准号:10742588
-
项目类别:
-
资助金额:$12.41万
-
财政年份:2020
-
负责人:Baek Kim
-
依托单位:
Elucidating SAMHD1 in DNA Double-Strand Break Repair
-
批准号:10418774
-
项目类别:
-
资助金额:$50.03万
-
财政年份:2020
-
负责人:Baek Kim
-
依托单位:
Elucidating SAMHD1 in DNA Double-Strand Break Repair
-
批准号:10663248
-
项目类别:
-
资助金额:$50.02万
-
财政年份:2020
-
负责人:Baek Kim
-
依托单位:
Lentivirus Replication Strategy and Pathogenesis
-
批准号:10700321
-
项目类别:
-
资助金额:$46.17万
-
财政年份:2018
-
负责人:Baek Kim
-
依托单位:
Structural and Chemical Analysis of Highly Potent ALLINI Platform
-
批准号:9789826
-
项目类别:
-
资助金额:$38.98万
-
财政年份:2018
-
负责人:Baek Kim
-
依托单位:
Lentivirus Replication Strategy and Pathogenesis
-
批准号:10078932
-
项目类别:
-
资助金额:$38.59万
-
财政年份:2018
-
负责人:Baek Kim
-
依托单位:
Structural and Chemical Analysis of Highly Potent ALLINI Platform
-
批准号:10239022
-
项目类别:
-
资助金额:$38.98万
-
财政年份:2018
-
负责人:Baek Kim
-
依托单位:
Lentivirus Replication Strategy and Pathogenesis
-
批准号:10319982
-
项目类别:
-
资助金额:$38.55万
-
财政年份:2018
-
负责人:Baek Kim
-
依托单位:
Structural and Chemical Analysis of Highly Potent ALLINI Platform
-
批准号:10455699
-
项目类别:
-
资助金额:$38.98万
-
财政年份:2018
-
负责人:Baek Kim
-
依托单位:
HIV Reverse Transcriptase-Mediated Mutagenesis
-
批准号:8915342
-
项目类别:
-
资助金额:$4.04万
-
财政年份:2013
-
负责人:Baek Kim
-
依托单位:
HIV Reverse Transcriptase-Mediated Mutagenesis
-
批准号:8561668
-
项目类别:
-
资助金额:$59.16万
-
财政年份:2013
-
负责人:Baek Kim
-
依托单位:
HIV Reverse Transcriptase-Mediated Mutagenesis
-
批准号:9068284
-
项目类别:
-
资助金额:$57.86万
-
财政年份:2013
-
负责人:Baek Kim
-
依托单位:
HIV Reverse Transcriptase-Mediated Mutagenesis
-
批准号:8730204
-
项目类别:
-
资助金额:$57.86万
-
财政年份:2013
-
负责人:Baek Kim
-
依托单位:
SAMHD1 controls dNTP pool and HIV sensitivity to NRTIs
-
批准号:8735968
-
项目类别:
-
资助金额:$29.43万
-
财政年份:2012
-
负责人:Baek Kim
-
依托单位:
海外基金